ACE and diabetes mellitus: Co-morbid conditions and demographic variables significantly associated with ACE inhibitor use included coronary artery disease, higher age, diabetes mellitus, chronic obstructive pulmonary disease, not currently smoking, congestive heart failure, prior stroke, no history of liver disease, and chronic renal disease.